[Effectiveness of postoperative adjuvant chemotherapy using S-1 plus CDDP for type 4 gastric cancer].
Gan To Kagaku Ryoho
; 40(3): 323-5, 2013 Mar.
Article
en Ja
| MEDLINE
| ID: mdl-23507592
ABSTRACT
BACKGROUND:
Our aim was to evaluate postoperative adjuvant chemotherapy using S-1 plus cisplatin(S-1/CDDP)for type 4 gastric cancer.METHODS:
We investigated 18 patients who had undergone curative operations for type 4 gastric cancer. They were classified into two groups of patients, one using S-1/CDDP(group A 9)and one using S-1 alone(group B 9), after surgery between 2000 and 2010. Median survival time(MST)and survival rates were reported retrospectively. Patients as- signed to group A were treated with the following regimen S-1, 80-120mg/day(body surface area 1. 25m2> 80mg/day, 1. 25-1. 5m2 100mg/day, 1. 5m2< 120mg), was administered for 21 consecutive days followed by a 14-day rest period, and CDDP, 60mg/m2, was administered on day 8 for 5 courses. After this course, S-1 80mg/m2 was given for 18 months. S- 1(80-120mg/day, body surface area 1. 25m2> 80mg/day, 1. 25-1. 5m2 100mg/day, 1. 5m2< 120mg)was administered for 28 days followed by 14-day rest as one course.RESULTS:
MST differed significantly between group A and group B (MST; group A 1, 603 vs group B 955 days). The overall survival rate at 5 years was 64. 8% in group A and 13% in group B, and the overall survival rate in group A was statistically better than that in group B(p=0. 02).CONCLUSION:
Postoperative adjuvant chemotherapy using S-1/CDDP for resected type 4 gastric cancer contributes to prolonged life, compared with using S-1 in overall survival.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Ácido Oxónico
/
Neoplasias Gástricas
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Tegafur
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Ja
Revista:
Gan To Kagaku Ryoho
Año:
2013
Tipo del documento:
Article
País de afiliación:
Japón